SRPT•benzinga•
Scotiabank Maintains Sector Perform on Sarepta Therapeutics, Lowers Price Target to $80
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga